NYBCe CCS Apheresis Collection Sites And Capacity

High-quality starting material is foundational to successful cell therapy research and manufacturing. Advanced cell sourcing capabilities bring together a diverse donor pool, precise matching to study specifications, and comprehensive donor management to ensure consistency from collection through delivery.

Experienced teams support optimal yield through tailored leukopak and hematopoietic progenitor cell collections, while maintaining strict adherence to clinical and regulatory requirements. Flexible apheresis options—including mobile collection at the point of care—enable greater convenience and scalability across sites. Integrated logistics and global distribution further streamline the path from collection to processing, manufacturing, or cryopreservation.

By combining scientific rigor with operational efficiency, organizations can reduce variability and accelerate progress across R&D and cGMP workflows. Discover how a more strategic approach to cell sourcing can strengthen your pipeline and improve reproducibility in critical applications.